Your browser doesn't support javascript.
loading
Tumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: a retrospective analysis of the CLEOPATRA study.
Luen, Stephen J; Salgado, Roberto; Fox, Stephen; Savas, Peter; Eng-Wong, Jennifer; Clark, Emma; Kiermaier, Astrid; Swain, Sandra M; Baselga, Jose; Michiels, Stefan; Loi, Sherene.
Afiliación
  • Luen SJ; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.
  • Salgado R; Department of Pathology, GZA-Hospitals, Antwerp, Belgium; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Fox S; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.
  • Savas P; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.
  • Eng-Wong J; Genentech, South San Francisco, CA, USA.
  • Clark E; Roche Products, Welwyn, UK.
  • Kiermaier A; Oncology Biomarker Development, Roche, Basel, Switzerland.
  • Swain SM; Lombardi Comprehensive Cancer Centre, Georgetown University, Washington, DC, USA.
  • Baselga J; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Michiels S; Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay, Villejuif, France.
  • Loi S; Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia. Electronic address: sherene.loi@petermac.org.
Lancet Oncol ; 18(1): 52-62, 2017 01.
Article en En | MEDLINE | ID: mdl-27964843
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Linfocitos Infiltrantes de Tumor / Receptor ErbB-2 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Linfocitos Infiltrantes de Tumor / Receptor ErbB-2 Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Australia